Scope Technologies to Present: 'Post-Quantum Threats' at DEF CON 33
Prnewswire· 2025-06-26 12:00
VANCOUVER, BC, June 26, 2025 /PRNewswire/ -- Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope Technologies" or the "Company") in partnership with Malware Village, today announces they will present at DEF CON 33 this August in Las Vegas. The Company's CTO Sean Prescott, and CEO Ted Carefoot, will deliver a featured session revealing how quantum computing is fueling the next generation of cyberattacks through malware enhanced by quantum algorithms.The talk, titled 'Quantum Malware: The E ...
New Off-the-Shelf Radiation-Hardened 15W DC-DC Power Converter for Space Applications
GlobeNewswire News Room· 2025-06-26 12:00
CHANDLER, Ariz., June 26, 2025 (GLOBE NEWSWIRE) -- Traditional space applications have long required space-grade components to help ensure the success of missions. With over 60 years of space heritage, Microchip Technology (Nasdaq: MCHP) continues to broaden its space portfolio and today announces the SA15-28 off-the-shelf radiation-hardened DC-DC 15W power converter with a companion SF100-28 EMI filter that are designed to meet MIL-STD-461 specifications. This space-grade power device is a standard, non-hy ...
Tokyo Lifestyle Co., Ltd. Announces Incorporation of Australian Subsidiary and Plan to Open a New Directly-Operated Store in Sydney
GlobeNewswire News Room· 2025-06-26 12:00
Tokyo, Japan, June 26, 2025 (GLOBE NEWSWIRE) -- Tokyo Lifestyle Co., Ltd. (“Tokyo Lifestyle” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, collectible cards, trending products as well as other products in Hong Kong, Japan, North America, Thailand and the United Kingdom, today announced the incorporation of a new subsidiary and its plan to open a directly operated store under its proprietary “Tokyo Li ...
Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression
Prnewswire· 2025-06-26 12:00
Phase 3 Top Line Results Expected Q2 2026SALT LAKE CITY, June 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery, today announced that the first patient has been dosed in its pivotal Phase 3 clinical trial of LPCN 1154 (oral brexanolone), its investigational oral treatment for postpartum depression (PPD).Following FDA feedback, this study is being conducted in an outpati ...
The AI Adoption Reality Check: Firms with AI Strategies are Twice as Likely to see AI-driven Revenue Growth; Those Without Risk Falling Behind
Prnewswire· 2025-06-26 12:00
NEW Thomson Reuters survey data reveals that only a quarter of organizations have a visible AI strategy. Time savings from AI could see a $32 billion opportunity on the table for the legal and tax industries in the U.S. aloneTORONTO, June 26, 2025 /PRNewswire/ -- Thomson Reuters (Nasdaq/TSX: TRI), a global content and technology company, today released its 2025 Future of Professionals report, which reveals a significant divide between organizations* that have adopted an AI strategy and those that have not. ...
SenesTech's Evolve™ Rodent Birth Control Proven in Urban Rodent Hotspots from Hong Kong to San Francisco
Prnewswire· 2025-06-26 12:00
Pallet and Container Orders Expected for Resupply and ExpansionSURPRISE, Ariz., June 26, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, today announced compelling results from two major urban deployments — one in Hong Kong and one in San Francisco — showing how pairing Evolve™ Rat Birth Control with traditional poison bait stations delivers faster, more sustainable rodent control where it's needed most.Gl ...
Big Ten and Big 12 Enter Historic Partnerships with PayPal to Enable Institutional Payments for Student-Athletes in New Revenue Sharing Model
Prnewswire· 2025-06-26 12:00
Multi-year partnerships will bring PayPal and Venmo to college campuses nationwideSAN JOSE, Calif., June 26, 2025 /PRNewswire/ -- PayPal Holdings, Inc. (NASDAQ: PYPL), a global leader in payments, today announced multi-year agreements with the Big Ten and Big 12 Conferences that will modernize the distribution of institutional payments from universities to student-athletes in a new revenue-sharing model. The new institutional payments initiative enables athletic departments to seamlessly dispense payments t ...
Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving
GlobeNewswire News Room· 2025-06-26 12:00
FREEHOLD, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that it entered into a definitive agreement with Qi Diagnostics Limited (“Qi Diagnostics”), a nanosensor-based diagnostic technologies company, to co-develop a VOC (volatile organic compound) nanosensor-based point-of-care cannabis breathalyzer. Through this strategic collaboration, Avalon, Q&A Distribution, LLC, a subsidi ...
Research Solutions & Third Iron Partner To Streamline Content Access For Academic Libraries
Prnewswire· 2025-06-26 12:00
Integration Delivers Full Coverage of Scholarly Content While Optimizing Costs And Workflow ComplexityHENDERSON, Nev., June 26, 2025 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a leading provider of AI-powered scientific research tools, announces a strategic integration with Third Iron's LibKey platform that enhances how researchers access scholarly content. The partnership integrates Article Galaxy Scholar (AGS) into LibKey's linking ecosystem, providing libraries with expanded options for essential ...
Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards
GlobeNewswire News Room· 2025-06-26 12:00
Recognition highlights EluPro™ Antibiotic-Eluting BioEnvelope’s impact on device protection for cardiac implantable electronic devices (CIEDs) and neurostimulators SILVER SPRING, Md., June 26, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, has been recognized with two prestigious honors—Innovation and Product Launches—in the 2025 Medical Device Network Excellence Awards. The awards celebrate Elutia’s advancements in drug el ...